These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37398872)

  • 21. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes.
    Greenhalgh J; Hockenhull J; Rao N; Dundar Y; Dickson RC; Bagust A
    Cochrane Database Syst Rev; 2010 May; (5):CD004587. PubMed ID: 20464732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-Eluting Balloon versus New-Generation Drug-Eluting Stent for the Treatment of In-Stent Restenosis: An Updated Systematic Review and Meta-Analysis.
    Cui KY; Lyu SZ; Zhang M; Song XT; Yuan F; Xu F
    Chin Med J (Engl); 2018 Mar; 131(5):600-607. PubMed ID: 29483397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: insights from a meta-analysis of 1462 patients.
    Lupi A; Rognoni A; Secco GG; Porto I; Nardi F; Lazzero M; Rossi L; Parisi R; Fattori R; Genoni G; Rosso R; Stella PR; Sheiban I; Bolognese L; Liistro F; Bongo AS; Agostoni P
    Int J Cardiol; 2013 Oct; 168(5):4608-16. PubMed ID: 23948110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endovascular treatment of infrapopliteal arteries: angioplasty vs stent in the drug-eluting era.
    Fanelli F; Cannavale A
    Eur Radiol; 2014 Apr; 24(4):793-8. PubMed ID: 24477689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-eluting balloon versus bare-mental stent and drug-eluting stent for de novo coronary artery disease: A systematic review and meta-analysis of 14 randomized controlled trials.
    Cui K; Lyu S; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang D; Dai J
    PLoS One; 2017; 12(4):e0176365. PubMed ID: 28445555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: an updated systematic review and meta-analysis.
    Ariyaratne TV; Ademi Z; Yap CH; Billah B; Rosenfeldt F; Yan BP; Reid CM
    Int J Cardiol; 2014 Sep; 176(2):346-53. PubMed ID: 25127976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis.
    Nairooz R; Saad M; Sardar P; Aronow WS
    Heart; 2017 Jul; 103(14):1096-1103. PubMed ID: 28115471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials.
    Madhavan MV; Howard JP; Naqvi A; Ben-Yehuda O; Redfors B; Prasad M; Shahim B; Leon MB; Bangalore S; Stone GW; Ahmad Y
    Eur Heart J; 2021 Jul; 42(27):2643-2654. PubMed ID: 34002202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
    Wallace EL; Abdel-Latif A; Charnigo R; Moliterno DJ; Brodie B; Matnani R; Ziada KM
    Am J Cardiol; 2012 Apr; 109(7):932-40. PubMed ID: 22221949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial.
    Wöhrle J; Scheller B; Seeger J; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Stachel G; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Jeger RV;
    JACC Cardiovasc Interv; 2021 Aug; 14(16):1789-1798. PubMed ID: 34412797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up.
    Cortese B; Testa G; Rivero F; Erriquez A; Alfonso F
    JACC Cardiovasc Interv; 2023 May; 16(9):1054-1061. PubMed ID: 37164603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-eluting stents: a systematic review and economic evaluation.
    Hill RA; Boland A; Dickson R; Dündar Y; Haycox A; McLeod C; Mujica Mota R; Walley T; Bagust A
    Health Technol Assess; 2007 Nov; 11(46):iii, xi-221. PubMed ID: 17999841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of drug eluting stent in-stent restenosis: A systematic review and meta-analysis.
    Goel SS; Dilip Gajulapalli R; Athappan G; Philip F; Gupta S; Murat Tuzcu E; Ellis SG; Mishkel G; Kapadia SR
    Catheter Cardiovasc Interv; 2016 May; 87(6):1080-91. PubMed ID: 26613637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Drug-Eluting Stent In-Stent Restenosis With Drug-Eluting Balloons: A Systematic Review and Meta-Analysis.
    Liu S; Worme M; Yanagawa B; Kumar N; Buller CE; Cheema AN; Bagai A
    J Invasive Cardiol; 2018 Oct; 30(10):360-366. PubMed ID: 30108189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness and safety of the RESTORE
    Tang YD; Qiao SB; Su X; Chen YD; Jin ZN; Chen H; Xu B; Kong XQ; Pang WY; Liu Y; Yu ZX; Li X; Li H; Zhao YY; Li W; Tian J; Guan CD; Xu B; Gao RL;
    J Geriatr Cardiol; 2018 Jul; 15(7):469-475. PubMed ID: 30364848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials.
    Lee JM; Park J; Kang J; Jeon KH; Jung JH; Lee SE; Han JK; Kim HL; Yang HM; Park KW; Kang HJ; Koo BK; Kim HS
    JACC Cardiovasc Interv; 2015 Mar; 8(3):382-394. PubMed ID: 25703886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review and economic analysis of drug-eluting coronary stents available in Australia.
    Lord SJ; Howard K; Allen F; Marinovich L; Burgess DC; King R; Atherton JJ
    Med J Aust; 2005 Nov; 183(9):464-71. PubMed ID: 16274347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis.
    Xiu WJ; Yang HT; Zheng YY; Ma YT; Xie X
    Cardiol Res Pract; 2018; 2018():7658145. PubMed ID: 30155288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug eluting balloons for de novo coronary lesions - a systematic review and meta-analysis.
    Fröhlich GM; Lansky AJ; Ko DT; Archangelidi O; De Palma R; Timmis A; Meier P
    BMC Med; 2013 May; 11():123. PubMed ID: 23657123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial.
    Mahfoud F; Farah A; Ohlow MA; Mangner N; Wöhrle J; Möbius-Winkler S; Weilenmann D; Leibundgut G; Cuculi F; Gilgen N; Kaiser C; Cattaneo M; Scheller B; Jeger RV
    Clin Res Cardiol; 2022 Jul; 111(7):806-815. PubMed ID: 35220449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.